[HTML][HTML] Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases

PBT Saputra, RB Kurniawan, D Trilistyoati… - Biomolecules and …, 2023 - ncbi.nlm.nih.gov
Vaccination is significant to control, mitigate, and recover from the destructive effects of
coronavirus disease 2019 (COVID-19). The incidence of myocarditis following COVID-19 …

[HTML][HTML] Relapsing myocarditis following initial recovery of post COVID-19 vaccination in two adolescent males–Case reports

D Amodio, EC Manno, N Cotugno, V Santilli… - Vaccine: X, 2023 - Elsevier
Whilst there has been significant public health benefits associated with global use of COVID-
19 spike protein vaccines, potential serious adverse events following immunization have …

[HTML][HTML] Recurrent cardiac tamponade following coronavirus disease 2019 mRNA vaccination: a case report

R Kaimori, H Nishida, T Yahiro, T Miura, T Iwami… - Cardiovascular …, 2024 - Elsevier
A 64-year-old woman with a history of subarachnoid hemorrhage, breast cancer, cervical
spine tumor, and syringomyelia developed recurrent pericardial effusion and cardiac …

[HTML][HTML] Cardiac Adverse Events Following COVID-19 Vaccination in Patients With Prior Vaccine-Associated Myocarditis

JR Montgomery, DL Hoffman, MA Ryan… - Federal …, 2023 - ncbi.nlm.nih.gov
Background Limited information exists to guide shared clinical decision making on COVID-
19 vaccination in persons with a prior history of vaccine-associated myocarditis, pericarditis …

[HTML][HTML] Renata J. Engler, MD

JR Montgomery, DL Hoffman, MA Ryan, RU Lee… - mdedge9-ma1.mdedge.com
Methods As part of the collaborative public health mission with the Centers for Disease
Control and Prevention (CDC) for enhanced vaccine AE surveillance, the Defense Health …